日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease: A Substudy of the PROMISE Randomized Clinical Trial

斑块体积对首次诊断为冠状动脉疾病患者的预后价值:PROMISE随机临床试验的子研究

Karády, Júlia; Mayrhofer, Thomas; Brendel, Jan M; Kolossváry, Márton; Langenbach, Marcel; Langenbach, Isabel; Baliyan, Vinit; Sturniolo, Audra K; Pagidipati, Neha; Lu, Michael T; Ferencik, Maros; Shah, Svati; Douglas, Pamela S; Foldyna, Borek

Aortic and Cardiac Structure From Routine CT Predict Cardiovascular Risk Beyond PREVENT and Coronary Calcium

常规CT扫描显示的心脏和主动脉结构可预测心血管风险,其预测能力优于PREVENT研究和冠状动脉钙化研究。

Oo, Daniel W; Jung, Matthias; Nürnberg, Leonard; Chandra, Jay; Sturniolo, Audra; Kerkovits, Nora; Jorshery, Saman Doroodgar; Langenbach, Marcel; Foldyna, Borek; Kiel, Douglas P; Aerts, Hugo J W L; Natarajan, Pradeep; Lu, Michael T; Raghu, Vineet K

OPPORTUNISTIC ASSESSMENT OF CARDIOVASCULAR RISK USING AI-DERIVED STRUCTURAL AORTIC AND CARDIAC PHENOTYPES FROM NON-CONTRAST CHEST COMPUTED TOMOGRAPHY

利用人工智能从非增强胸部计算机断层扫描中提取的主动脉和心脏结构表型进行心血管风险机会性评估

Oo, Daniel W; Sturniolo, Audra; Jung, Matthias; Langenbach, Marcel; Foldyna, Borek; Kiel, Douglas P; Aerts, Hugo Jwl; Natarajan, Pradeep; Lu, Michael T; Raghu, Vineet K

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.

匹伐他汀对 HIV 患者冠状动脉疾病和炎症生物标志物的影响:REPRIEVE 随机临床试验的机制子研究

Lu Michael T, Ribaudo Heather, Foldyna Borek, Zanni Markella V, Mayrhofer Thomas, Karady Julia, Taron Jana, Fitch Kathleen V, McCallum Sara, Burdo Tricia H, Paradis Kayla, Hedgire Sandeep S, Meyersohn Nandini M, DeFilippi Christopher, Malvestutto Carlos D, Sturniolo Audra, Diggs Marissa, Siminski Sue, Bloomfield Gerald S, Alston-Smith Beverly, Desvigne-Nickens Patrice, Overton Edgar T, Currier Judith S, Aberg Judith A, Fichtenbaum Carl J, Hoffmann Udo, Douglas Pamela S, Grinspoon Steven K